Liquid chip kit for diagnosing lung cancer
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- HENGDIAN GRP JIAYUAN CHEM
- Publication Date
- 2013-11-13
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of medicine and biology, in particular to a liquid phase chip kit for lung cancer diagnosis. Background technique
[0002] Lung cancer is currently the malignant tumor with the highest morbidity and mortality worldwide. In the past 20 years, due to the vigorous promotion of smoking cessation, the incidence of male lung cancer in Western countries such as Europe and the United States has begun to decline. But the incidence of lung cancer in women continues to rise. my country is a big country in the production and sales of cigarettes, regardless of men or women. The incidence of lung cancer has continued to rise, especially in women. Clinical studies have shown that the cure rate of carcinoma in situ is close to 100%. The 5-year survival rate of patients with stage I lung cancer is 60% to 90%, while the 5-year survival rate of patients with stage IIIb and IV lung cancer is only 5% to 20%. It suggested that early d...